184 related articles for article (PubMed ID: 17675579)
1. Notch2 signaling induces apoptosis and inhibits human MDA-MB-231 xenograft growth.
O'Neill CF; Urs S; Cinelli C; Lincoln A; Nadeau RJ; León R; Toher J; Mouta-Bellum C; Friesel RE; Liaw L
Am J Pathol; 2007 Sep; 171(3):1023-36. PubMed ID: 17675579
[TBL] [Abstract][Full Text] [Related]
2. NOTCH-1 and NOTCH-4 are novel gene targets of PEA3 in breast cancer: novel therapeutic implications.
Clementz AG; Rogowski A; Pandya K; Miele L; Osipo C
Breast Cancer Res; 2011 Jun; 13(3):R63. PubMed ID: 21679465
[TBL] [Abstract][Full Text] [Related]
3. Notch2 activation by benzyl isothiocyanate impedes its inhibitory effect on breast cancer cell migration.
Kim SH; Sehrawat A; Singh SV
Breast Cancer Res Treat; 2012 Aug; 134(3):1067-79. PubMed ID: 22476855
[TBL] [Abstract][Full Text] [Related]
4. Withaferin A causes activation of Notch2 and Notch4 in human breast cancer cells.
Lee J; Sehrawat A; Singh SV
Breast Cancer Res Treat; 2012 Nov; 136(1):45-56. PubMed ID: 22965833
[TBL] [Abstract][Full Text] [Related]
5. Inflammation dysregulates Notch signaling in endothelial cells: implication of Notch2 and Notch4 to endothelial dysfunction.
Quillard T; Devallière J; Coupel S; Charreau B
Biochem Pharmacol; 2010 Dec; 80(12):2032-41. PubMed ID: 20643108
[TBL] [Abstract][Full Text] [Related]
6. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors.
Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A
Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481
[TBL] [Abstract][Full Text] [Related]
7. Midkine promotes neuroblastoma through Notch2 signaling.
Kishida S; Mu P; Miyakawa S; Fujiwara M; Abe T; Sakamoto K; Onishi A; Nakamura Y; Kadomatsu K
Cancer Res; 2013 Feb; 73(4):1318-27. PubMed ID: 23243020
[TBL] [Abstract][Full Text] [Related]
8. Impaired Notch4 activity elicits endothelial cell activation and apoptosis: implication for transplant arteriosclerosis.
Quillard T; Coupel S; Coulon F; Fitau J; Chatelais M; Cuturi MC; Chiffoleau E; Charreau B
Arterioscler Thromb Vasc Biol; 2008 Dec; 28(12):2258-65. PubMed ID: 18802018
[TBL] [Abstract][Full Text] [Related]
9. Targeting Notch signaling with a Notch2/Notch3 antagonist (tarextumab) inhibits tumor growth and decreases tumor-initiating cell frequency.
Yen WC; Fischer MM; Axelrod F; Bond C; Cain J; Cancilla B; Henner WR; Meisner R; Sato A; Shah J; Tang T; Wallace B; Wang M; Zhang C; Kapoun AM; Lewicki J; Gurney A; Hoey T
Clin Cancer Res; 2015 May; 21(9):2084-95. PubMed ID: 25934888
[TBL] [Abstract][Full Text] [Related]
10. Not all NOTCH Is Created Equal: The Oncogenic Role of NOTCH2 in Bladder Cancer and Its Implications for Targeted Therapy.
Hayashi T; Gust KM; Wyatt AW; Goriki A; Jäger W; Awrey S; Li N; Oo HZ; Altamirano-Dimas M; Buttyan R; Fazli L; Matsubara A; Black PC
Clin Cancer Res; 2016 Jun; 22(12):2981-92. PubMed ID: 26769750
[TBL] [Abstract][Full Text] [Related]
11. PEA-15 inhibits tumorigenesis in an MDA-MB-468 triple-negative breast cancer xenograft model through increased cytoplasmic localization of activated extracellular signal-regulated kinase.
Bartholomeusz C; Gonzalez-Angulo AM; Kazansky A; Krishnamurthy S; Liu P; Yuan LX; Yamasaki F; Liu S; Hayashi N; Zhang D; Esteva FJ; Hortobagyi GN; Ueno NT
Clin Cancer Res; 2010 Mar; 16(6):1802-11. PubMed ID: 20215547
[TBL] [Abstract][Full Text] [Related]
12. Notch2 signaling sensitizes endothelial cells to apoptosis by negatively regulating the key protective molecule survivin.
Quillard T; Devalliere J; Chatelais M; Coulon F; Séveno C; Romagnoli M; Barillé Nion S; Charreau B
PLoS One; 2009 Dec; 4(12):e8244. PubMed ID: 20011512
[TBL] [Abstract][Full Text] [Related]
13. Differential Regulation of NOTCH2 and NOTCH3 Contribute to Their Unique Functions in Vascular Smooth Muscle Cells.
Baeten JT; Lilly B
J Biol Chem; 2015 Jun; 290(26):16226-37. PubMed ID: 25957400
[TBL] [Abstract][Full Text] [Related]
14. Notch2-induced COX-2 expression enhancing gastric cancer progression.
Tseng YC; Tsai YH; Tseng MJ; Hsu KW; Yang MC; Huang KH; Li AF; Chi CW; Hsieh RH; Ku HH; Yeh TS
Mol Carcinog; 2012 Dec; 51(12):939-51. PubMed ID: 21976141
[TBL] [Abstract][Full Text] [Related]
15. Withaferin A inhibits in vivo growth of breast cancer cells accelerated by Notch2 knockdown.
Kim SH; Hahm ER; Arlotti JA; Samanta SK; Moura MB; Thorne SH; Shuai Y; Anderson CJ; White AG; Lokshin A; Lee J; Singh SV
Breast Cancer Res Treat; 2016 May; 157(1):41-54. PubMed ID: 27097807
[TBL] [Abstract][Full Text] [Related]
16. The role of polycomb group protein Bmi-1 and Notch4 in breast cancer stem cell inhibition by benzyl isothiocyanate.
Kim SH; Singh SV
Breast Cancer Res Treat; 2015 Feb; 149(3):681-92. PubMed ID: 25663545
[TBL] [Abstract][Full Text] [Related]
17. Notch4 intracellular domain binding to Smad3 and inhibition of the TGF-beta signaling.
Sun Y; Lowther W; Kato K; Bianco C; Kenney N; Strizzi L; Raafat D; Hirota M; Khan NI; Bargo S; Jones B; Salomon D; Callahan R
Oncogene; 2005 Aug; 24(34):5365-74. PubMed ID: 16007227
[TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin Q: a selective STAT3 activation inhibitor with potent antitumor activity.
Sun J; Blaskovich MA; Jove R; Livingston SK; Coppola D; Sebti SM
Oncogene; 2005 May; 24(20):3236-45. PubMed ID: 15735720
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying the growth inhibitory effects of the cyclo-oxygenase-2 inhibitor celecoxib in human breast cancer cells.
Basu GD; Pathangey LB; Tinder TL; Gendler SJ; Mukherjee P
Breast Cancer Res; 2005; 7(4):R422-35. PubMed ID: 15987447
[TBL] [Abstract][Full Text] [Related]
20. Notch promotes recurrence of dormant tumor cells following HER2/neu-targeted therapy.
Abravanel DL; Belka GK; Pan TC; Pant DK; Collins MA; Sterner CJ; Chodosh LA
J Clin Invest; 2015 Jun; 125(6):2484-96. PubMed ID: 25961456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
